Treatment of acute stroke with hyperbaric oxygen: time window for efficacy. | Canada Hyperbarics Skip to main content
Retrospective Study Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc 2011

Treatment of acute stroke with hyperbaric oxygen: time window for efficacy.

McCormick JG, Houle TT, Saltzman HA, Whaley RC, Roy RC — Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc, 2011

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers conducted a retrospective statistical analysis of a 1966 study involving 22 stroke patients treated with hyperbaric oxygen (HBO2) to examine the influence of time post-stroke on recovery.

What They Found

They found that time post-stroke was the only significant factor for recovery, with each passing hour decreasing the chance of at least partial transient recovery by 62%. Of 13 patients treated within one to five hours, nine (41% of the total 22) showed some recovery, though only two had permanent recovery. Beyond six hours post-stroke, only one patient (11%) experienced partial recovery with relapse.

What This Means for Canadian Patients

For Canadian patients experiencing acute stroke, these findings suggest that hyperbaric oxygen (HBO2) treatment may be most effective if administered within the first three hours post-stroke. HBO2 could potentially be used to assess the risk-benefit of giving rtPA, potentially improving outcomes for those eligible for this therapy.

Canadian Relevance

This study has no direct Canadian connection as it was not conducted in Canada, nor did it involve Canadian researchers or patients.

Study Limitations

This study is limited by its retrospective design, small sample size of 22 patients, and reliance on data from a 1966 study.

Was this summary helpful?

Study Details

Study Type Retrospective Study
Category Neurological
Source Pubmed
PubMed ID 22013759
Year Published 2011
Journal Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc
MeSH Terms Adult; Fibrinolytic Agents; Humans; Hyperbaric Oxygenation; Middle Aged; Recombinant Proteins; Recovery of Function; Recurrence; Regression Analysis; Retrospective Studies; Stroke; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.